1. Home
  2. BCG vs BRNS Comparison

BCG vs BRNS Comparison

Compare BCG & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCG
  • BRNS
  • Stock Information
  • Founded
  • BCG 2016
  • BRNS 2016
  • Country
  • BCG United States
  • BRNS United Kingdom
  • Employees
  • BCG N/A
  • BRNS N/A
  • Industry
  • BCG
  • BRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BCG
  • BRNS Health Care
  • Exchange
  • BCG Nasdaq
  • BRNS Nasdaq
  • Market Cap
  • BCG 41.3M
  • BRNS 36.0M
  • IPO Year
  • BCG N/A
  • BRNS 2021
  • Fundamental
  • Price
  • BCG $2.00
  • BRNS $1.00
  • Analyst Decision
  • BCG
  • BRNS Strong Buy
  • Analyst Count
  • BCG 0
  • BRNS 1
  • Target Price
  • BCG N/A
  • BRNS $3.00
  • AVG Volume (30 Days)
  • BCG 8.9K
  • BRNS 17.8K
  • Earning Date
  • BCG 08-14-2025
  • BRNS 08-07-2025
  • Dividend Yield
  • BCG N/A
  • BRNS N/A
  • EPS Growth
  • BCG N/A
  • BRNS N/A
  • EPS
  • BCG N/A
  • BRNS N/A
  • Revenue
  • BCG $172,860,000.00
  • BRNS $14,969,000.00
  • Revenue This Year
  • BCG N/A
  • BRNS N/A
  • Revenue Next Year
  • BCG N/A
  • BRNS N/A
  • P/E Ratio
  • BCG N/A
  • BRNS N/A
  • Revenue Growth
  • BCG 7.36
  • BRNS 4381.74
  • 52 Week Low
  • BCG $1.71
  • BRNS $0.64
  • 52 Week High
  • BCG $6.55
  • BRNS $1.58
  • Technical
  • Relative Strength Index (RSI)
  • BCG N/A
  • BRNS 55.94
  • Support Level
  • BCG N/A
  • BRNS $0.90
  • Resistance Level
  • BCG N/A
  • BRNS $1.10
  • Average True Range (ATR)
  • BCG 0.00
  • BRNS 0.06
  • MACD
  • BCG 0.00
  • BRNS 0.01
  • Stochastic Oscillator
  • BCG 0.00
  • BRNS 60.00

About BCG Binah Capital Group Inc. Common Stock

Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

Share on Social Networks: